Scilex Holding CoSCLXEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 3.00% | 89.6M | ▼ -33.40pp | 2024-04-25 |
| Sorrento Therapeutics, Inc. | 1.30% | 1.9M | ▼ -42.00pp | 2023-09-26 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.